FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004358048> ?p ?o ?g. }

• W2004358048 endingPage "81" @default.
• W2004358048 startingPage "73" @default.
• W2004358048 abstract "The aim of the present investigation was to evaluate the percutaneous absorption of tolterodine (TOL) using O-acylmenthol derivatives as enhancers as well as to correlate their enhancing activity under in vitro and in vivo conditions. The in vitro permeation studies of TOL were conducted in isopropyl myristate (IPM) solution or from patches in side-by-side diffusion cells. TOL pharmacokinetic parameters were determined after intravenous administration and topical application of patches without enhancer or with l-menthol and (E)-2-isopropyl-5-methylcyclohexyl octadec-9-enoate (M-OA) as enhancers in rats. The in vitro permeation studies indicated that M-OA was the most promising enhancer for transdermal delivery, as 2-isopropyl-5-methylcyclohexyl 2-hydroxypanoate (M-LA) was merely effective in IPM solution. There was no significant difference between the control and l-menthol group in terms of the flux before patches were removed, while the skin reservoir effects of the enhancer-containing groups were significantly greater than that of the control group. The mean steady-state plasma concentrations after applying patches without enhancer or with l-menthol and M-OA as enhancers were 0.89, 0.84 and 1.47 microg/mL, respectively. The in vivo results observed from the three types of patches in rats were in good agreement with the plasma concentrations predicted from the in vitro data." @default.
• W2004358048 created "2016-06-24" @default.
• W2004358048 creator A5022409758 @default.
• W2004358048 creator A5022581605 @default.
• W2004358048 creator A5038805449 @default.
• W2004358048 creator A5043877502 @default.
• W2004358048 creator A5049347603 @default.
• W2004358048 creator A5064323494 @default.
• W2004358048 creator A5073883296 @default.
• W2004358048 creator A5074886105 @default.
• W2004358048 date "2009-06-01" @default.
• W2004358048 modified "2023-09-26" @default.
• W2004358048 title "Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation" @default.
• W2004358048 cites W1968157550 @default.
• W2004358048 cites W1968629246 @default.
• W2004358048 cites W1975258802 @default.
• W2004358048 cites W1981790549 @default.
• W2004358048 cites W1983009815 @default.
• W2004358048 cites W1989856470 @default.
• W2004358048 cites W1994297413 @default.
• W2004358048 cites W1994441888 @default.
• W2004358048 cites W1997531887 @default.
• W2004358048 cites W1999806354 @default.
• W2004358048 cites W2009143714 @default.
• W2004358048 cites W2014743489 @default.
• W2004358048 cites W2017954359 @default.
• W2004358048 cites W2024975356 @default.
• W2004358048 cites W2025434082 @default.
• W2004358048 cites W2035874674 @default.
• W2004358048 cites W2038629387 @default.
• W2004358048 cites W2053420603 @default.
• W2004358048 cites W2058269012 @default.
• W2004358048 cites W2062989783 @default.
• W2004358048 cites W2067857128 @default.
• W2004358048 cites W2074974363 @default.
• W2004358048 cites W2077092685 @default.
• W2004358048 cites W2077108403 @default.
• W2004358048 cites W2079014824 @default.
• W2004358048 cites W2079859568 @default.
• W2004358048 cites W2088555693 @default.
• W2004358048 cites W2149677267 @default.
• W2004358048 cites W2152830203 @default.
• W2004358048 cites W220109606 @default.
• W2004358048 cites W2326301554 @default.
• W2004358048 cites W2951996135 @default.
• W2004358048 doi "https://doi.org/10.1016/j.ijpharm.2009.03.005" @default.
• W2004358048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19446762" @default.
• W2004358048 hasPublicationYear "2009" @default.
• W2004358048 type Work @default.
• W2004358048 sameAs 2004358048 @default.
• W2004358048 citedByCount "34" @default.
• W2004358048 countsByYear W20043580482012 @default.
• W2004358048 countsByYear W20043580482013 @default.
• W2004358048 countsByYear W20043580482014 @default.
• W2004358048 countsByYear W20043580482015 @default.
• W2004358048 countsByYear W20043580482016 @default.
• W2004358048 countsByYear W20043580482017 @default.
• W2004358048 countsByYear W20043580482018 @default.
• W2004358048 countsByYear W20043580482019 @default.
• W2004358048 countsByYear W20043580482020 @default.
• W2004358048 countsByYear W20043580482022 @default.
• W2004358048 crossrefType "journal-article" @default.
• W2004358048 hasAuthorship W2004358048A5022409758 @default.
• W2004358048 hasAuthorship W2004358048A5022581605 @default.
• W2004358048 hasAuthorship W2004358048A5038805449 @default.
• W2004358048 hasAuthorship W2004358048A5043877502 @default.
• W2004358048 hasAuthorship W2004358048A5049347603 @default.
• W2004358048 hasAuthorship W2004358048A5064323494 @default.
• W2004358048 hasAuthorship W2004358048A5073883296 @default.
• W2004358048 hasAuthorship W2004358048A5074886105 @default.
• W2004358048 hasConcept C112705442 @default.
• W2004358048 hasConcept C125287762 @default.
• W2004358048 hasConcept C150903083 @default.
• W2004358048 hasConcept C159985019 @default.
• W2004358048 hasConcept C178790620 @default.
• W2004358048 hasConcept C185592680 @default.
• W2004358048 hasConcept C192562407 @default.
• W2004358048 hasConcept C202751555 @default.
• W2004358048 hasConcept C205679159 @default.
• W2004358048 hasConcept C207001950 @default.
• W2004358048 hasConcept C2779783494 @default.
• W2004358048 hasConcept C2780194911 @default.
• W2004358048 hasConcept C41625074 @default.
• W2004358048 hasConcept C43617362 @default.
• W2004358048 hasConcept C50670333 @default.
• W2004358048 hasConcept C55493867 @default.
• W2004358048 hasConcept C71924100 @default.
• W2004358048 hasConcept C86803240 @default.
• W2004358048 hasConcept C98274493 @default.
• W2004358048 hasConceptScore W2004358048C112705442 @default.
• W2004358048 hasConceptScore W2004358048C125287762 @default.
• W2004358048 hasConceptScore W2004358048C150903083 @default.
• W2004358048 hasConceptScore W2004358048C159985019 @default.
• W2004358048 hasConceptScore W2004358048C178790620 @default.
• W2004358048 hasConceptScore W2004358048C185592680 @default.
• W2004358048 hasConceptScore W2004358048C192562407 @default.
• W2004358048 hasConceptScore W2004358048C202751555 @default.
• W2004358048 hasConceptScore W2004358048C205679159 @default.

• next